US biotech VYNE Therapeutics has agreed to merge with privately held Yarrow Bioscience in an all-stock transaction, pivoting ...

US healthcare giant Johnson & Johnson announced that the US Food and Drug Administration (FDA) approved Rybrevant Fasbro ...

An Expert View piece looking forward to next year from the global strategy consultancy's Simon Middleton, head, Europe Life ...

UK pharma major GSK yesterday announced that the US Food and Drug Administration (FDA) has approved Exdensur ...

US biopharma Insmed Incorporated has announced that the Phase IIb BiRCh study of brensocatib in chronic rhinosinusitis ...

California, USA-based Vistagen yesterday announced that the PALISADE-3 Phase III study of intranasal fasedienol for the acute ...

US biotech Cytokinetics (Nasdaq: CYTK) has secured the first global approval for its cardiac myosin inhibitor aficamten, ...

RNAi therapeutics company Alnylam Pharmaceuticals has announced the planned expansion of its manufacturing facility in Norton ...

Japanese drugmaker Takeda has announced positive topline results for two pivotal Phase III studies of zasocitinib (TAK-279), ...

Cambridge, USA-based CAMP4 Therapeutics has entered into a strategic research, collaboration and license agreement with UK ...

US biotech Incyte yesterday revealed that the European Commission (EC) has approved Minjuvi (tafasitamab) in combination with ...

Sino-US biotech Harbour BioMed, which is focused on the discovery and development of novel antibody therapeutics in ...